← SynDRA
DORAMAPIMOD
SynDRA canonical compound SYN0003937 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | MAPK12 |
| Mechanism of action | P38 MAPK inhibitor |
All known targets
- MAPK14
- MAPK11
- MAPK12
- MAPK13
- DDR2
- HCK
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
- MAPK11 INHIBITOR
- MAPK12 INHIBITOR
- MAPK13 INHIBITOR
- HCK INHIBITOR
Cross-references
Synonyms
- BIRB-796
- BIRB 0796
- BIRB-796 BS
- BIRB0796BS
- DORAMAPIMOD (BIRB-796)
- GW839464X
- BIRB 796
- BIRB 796 (Doramapimod)
- BIRB796
- UNII-HO1A8B3YVV
- 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA
- 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea
- HO1A8B3YVV
- CHEMBL103667
- 3-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-1-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea
- CHEBI:40953
- MVCOAUNKQVWQHZ-UHFFFAOYSA-N
- C31H37N5O3
- 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2
- BIRB 796 BS
- DTXCID9028883
- doramapimodum
- RefChem:590371
- MFCD09752957
- Doramapimod (BIRB-796)
- BIRB-0796
- NCGC00241104-01
- B96
- CAS-285983-48-4
- Doramapimod (USAN/INN)
- Doramapimod [USAN:INN]
- Doramapimod (GMP)
- Kinome_2137
- 1kv2
- BIRB 796,Doramapimod
- diaryl urea compound 10
- DORAMAPIMOD [INN]
- DORAMAPIMOD [USAN]
Look up DORAMAPIMOD in the interactive SynDRA portal →